Androgen Insensitivity Syndrome (AIS) via the Androgen Receptor (AR) Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7577
1 Gene
Familial Amyloidosis (hATTR) via the TTR Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8983
1 Gene
Autosomal Recessive Nonsyndromic Hearing Loss via NGS and Sanger of the STRC Gene
NGS and Sanger Sequencing
3 - 4 weeks (12 - 20 days STAT)•Test 16223
1 Gene
PGmito - Mitochondrial Genome Sequencing
Long Range PCR and NGS
3 - 4 weeks•Test 12980
37 Genes
ENPP1 and ABCC6 Genetic Testing (SP‑051)
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 7555
2 Genes
DetectHypopara™ Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 15739
26 Genes
X-Linked Hypoparathyroidism via the Interstitial Deletion-Insertion Involving Chromosomes 2p25.3 and Xq27.1, Near SOX3
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 4201
1 Gene
Lynch Syndrome via the MSH2 Exons 1-7 Inversion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 906
1 Gene
Oculocutaneous Albinism Type 2 (OCAII) via the OCA2 Known Intragenic Gross Deletion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 3738
1 Gene
Galactosemia Type I (Classic and Variant Galactosemia) via the GALT Gene, 5.5 kb Common Deletion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 2310
1 Gene
Paroxysmal Paralytic Rhabdomyolysis via the LPIN1 Gene, Exons 18-19 Deletion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 319
1 Gene
Manitoba Oculotrichoanal Syndrome (MOTA) via the FREM1 Exon 8-23 Deletion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 3782
1 Gene
Targeted Variants - Mitochondrial Genome Testing
Long Range PCR and NGS
2 - 3 weeks•Test 14028
PGxome® - Rapid Whole Exome Test
Exome Platform with CNV
7 - 16 days•Test 13001
Targeted Testing for Sequence Variants
Sanger Sequencing
2 - 3 weeks (6 - 14 days STAT)•Test 100
Targeted Variants - Deletion/Duplication Testing
Targeted PCR
2 - 3 weeks•Test 1400
Cell Cultures
Cell cultures are performed by Allele Diagnostics
N/A•Test 995
Generalized Arterial Calcification of Infancy and Pseudoxanthoma Elasticum (PXE) via the ABCC6 Gene
NGS with CNV (PGselect platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7857
1 Gene
Ehlers-Danlos Syndromes (EDS) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10383
65 Genes
Parkinson Disease via the LRRK2 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 11457
1 Gene
Rett Syndrome via the MECP2 Gene
NGS with CNV (PGselect platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7271
1 Gene
Amyotrophic Lateral Sclerosis / Motor Neuron Disease via the FUS Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 6927
X-linked Retinitis Pigmentosa (XLRP) via the RPGR Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 11013
1 Gene
Peroxisomal Biogenesis Disorder-Zellweger Spectrum Disorder (PBD-ZSD) Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 12655
13 Genes
No-Cost Genetic Testing Program for Thymidine Kinase 2 Deficiency
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 12031
55 Genes
Early-Onset Bilateral Cataracts Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 13315
66 Genes
Ionis Familial Chylomicronemia Syndrome (FCS) Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 13025
7 Genes
No-charge Sponsored Testing Program for Rare Genetic Diseases of Obesity
Sponsored TestNGS with CNV (PGselect Platform)
2 - 3 weeks•Test 15187
87 Genes
No-Cost Genetic Testing Program for Thymidine Kinase 2 Deficiency
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 12029
1 Gene
Inozyme ABCC6 Deficiency Genetic Test Program
Sponsored TestNGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7857
1 Gene
Amyotrophic Lateral Sclerosis (ALS) Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 15479
29 Genes
CardioNavigATTR Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 16207
36 Genes
NeuroNavigATTR Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 16209
66 Genes
Xeris Pharmaceuticals Uncovering Periodic Paralysis
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 16099
6 Genes
Alnylam Act® Acute Hepatic Porphyria Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 16301
10 Genes
Alnylam Act® Primary Hyperoxaluria Type 1 Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 16035
45 Genes
My Retina Tracker Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 16023
110 Genes
No-Charge Genetic Testing and Counseling Program for Sensorineural Hearing Loss
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 to 4 weeks•Test 16033
274 Genes
No-Cost Genetic Testing Program for Friedreich Ataxia (FA)
Sponsored TestRepeat-Primed PCR and Fragment Length Assay
2 - 3 weeks•Test 20060
1 Gene
Susceptibility to Infection Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16093
64 Genes
NavigATTR Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 15139
1 Gene
Decode DEB Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 15787
27 Genes
Amplify™ Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 15747
269 Genes
Alnylam Act® Primary Hyperoxaluria Type 1 Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 16029
3 Genes
Rapid Prenatal Whole Genome Chromosomal Microarray (CMA-ISCA) Test
CMA
6 - 10 days•Test 3780
PGxome® - Whole Exome Test
Exome Platform with CNV
3 - 5 weeks•Test 5000
Whole Genome Chromosomal Microarray (CMA-ISCA)
CMA
3 - 5 weeks•Test 2000
Cerebral Cavernous Malformations via the KRIT1/CCM1 Gene, Exon 10
Sanger Sequencing
3 - 4 weeks (12 - 19 days STAT)•Test 125
1 Gene
Ectodermal Dysplasia via the EDA Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7631
1 Gene
Fibrodysplasia Ossificans progressiva (FOP) via the ACVR1 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8293
1 Gene
Idiopathic Hypogonadotropic Hypogonadism (IHH) via the GNRHR Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9113
1 Gene
Homocystinuria via the CBS Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9369
1 Gene
Allan-Herndon-Dudley Syndrome or Monocarboxylate Transporter 8 Deficiency via the SLC16A2 Gene
Sanger Sequencing
3 - 4 weeks (12 - 19 days STAT)•Test 2086
1 Gene
Pantothenate Kinase-Associated Neurodegeneration (PKAN, Hallervorden-Spatz Disease) via the PANK2 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8347
1 Gene
Neuroblastoma Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5057
15 Genes
Parkinson Disease Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10337
24 Genes
Deafness, Autosomal Recessive 9 (DFNB9) via the OTOF Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 11549
1 Gene
Optic Atrophy and Hereditary Spastic Paraplegia via the SPG7 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 11707
1 Gene
Familial Partial Lipodystrophy (FPLD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12605
16 Genes
Bernard-Soulier Syndrome via the GP9 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9227
1 Gene
Combined Immunodeficiencies with Syndromic Features Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16097
67 Genes
Congenital Defects of Phagocytes Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16091
43 Genes
Complement Deficiencies Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16089
26 Genes
Autoinflammatory Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16085
57 Genes
Adrenocortical Carcinoma (ACC) Panel
NGS with CNV (PGselect platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16213
8 Genes
Comprehensive Endocrine Cancer Panel
NGS with CNV (PGselect platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16211
42 Genes
Hereditary Diffuse Leukoencephalopathy with Spheroids via the CSF1R Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10665
1 Gene
Sarcoma Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7971
35 Genes
Hereditary Central Nervous System/Brain Cancer Panel
NGS with CNV (PGselect platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7969
26 Genes
Immune Dysregulation Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16095
59 Genes
Antibody Deficiency Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16083
41 Genes
Cellular and Humoral Immunodeficiency Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16087
62 Genes
Severe Skeletal Conditions Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 15771
85 Genes
Overgrowth and Macrocephaly Syndromes Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (6 - 12 days STAT)•Test 3449
112 Genes
Nevoid Basal Cell Carcinoma Syndrome Panel
NGS with CNV (PGselect platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16205
3 Genes
Gene-Centric CNV Analysis via aCGH
CNV via aCGH
2 - 4 weeks (9 - 21 days STAT)•Test 600
PGnome® - Rapid Whole Genome Test
Genome Platform with SV
8 - 16 days•Test 14000
PGnome® - Health Screen Genome Test
Genome Platform with SV
3 - 5 weeks•Test 9000
PGnome® - Whole Genome Test
Genome Platform with SV
3 - 5 weeks•Test 7000
PGxome® - Health Screen Exome Test
Exome Platform with CNV
3 - 5 weeks•Test 4000
PGxome® - Prenatal Whole Exome Test
Exome Platform with CNV
7 - 16 days•Test 14010
Polycystic Liver Disease (PLD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10227
8 Genes
Extract and Hold
Sequencing with CNV PGxome
3 weeks (STAT 2 weeks)•Test 14033
Comprehensive Brain Malformation Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12619
336 Genes
Dyskeratosis Congenita (DC) and Related Telomere Biology Disorders Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3005
17 Genes
Friedreich Ataxia (FRDA) via the FXN GAA Repeat Expansion
Repeat-Primed PCR & Fragment Length
1 - 2 weeks (6 - 10 days STAT)•Test 20060
1 Gene
PGmax™ - Comprehensive Epilepsy and Seizure Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 16005
1455 Genes
Elevated Levels of C14 and C14:1 Acylcarnitine via the ACADVL Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16043
1 Gene
Elevated Levels of C6, C8 and C10 Acylcarnitine via the ACADM Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16045
1 Gene
Hyperphenylalaninemia/Phenylalanine Hydroxylase Deficiency via the PAH Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9725
1 Gene
Elevated Levels of C0/(C16+C18) Acylcarnitine via the CPT1A Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16041
1 Gene
Low Levels of Free Carnitine (C0) via the SLC22A5 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16039
1 Gene
Epilepsy and Seizure Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7347
410 Genes
Hypoglycemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12057
171 Genes
Amelogenesis and Dentinogenesis Imperfecta Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (6 - 12 days STAT)•Test 5207
34 Genes
Alzheimer's Disease, Familial, Plus APOE Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 15781
4 Genes
Congenital Abnormalities of the Kidney and Urinary Tract (CAKUT) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 2667
77 Genes
L1 Syndrome via the L1CAM Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7719
1 Gene
Cleft Lip/Cleft Palate Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10657
165 Genes
Osteogenesis Imperfecta Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12047
30 Genes
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10149
10 Genes
Autosomal Dominant and Recessive Polycystic Kidney Disease (ADPKD and ARPKD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10189
13 Genes
Dilated Cardiomyopathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 1339
68 Genes
Thrombocytopenia Panel - Expanded
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10393
33 Genes
Galactosemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5013
4 Genes
Tyrosinemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5011
4 Genes
Hereditary Hemorrhagic Telangiectasia (HHT) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10131
6 Genes
Glycogen Storage Disease (GSD) and Disorders of Glucose Metabolism Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10385
33 Genes
Spondylocostal Dysostosis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10213
6 Genes
Connective Tissue Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7947
101 Genes
Congenital Limb Malformation Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5065
99 Genes
Primary Aldosteronism Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3023
4 Genes
Oculocutaneous Albinism and Hypopigmentation Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10313
31 Genes
Differences of Sex Development (DSD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4509
158 Genes
Nephrotic Syndrome (NS)/Focal Segmental Glomerulosclerosis (FSGS) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10417
72 Genes
Pulmonary Arterial Hypertension (PAH) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12625
11 Genes
Disorders Related to Metabolism of Cobalamin, Folate and Homocysteine Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10397
39 Genes
Congenital Adrenal Hyperplasia (CAH) via the CYP21A2 Gene
Sanger Sequencing
3 - 4 weeks (12 - 20 days STAT)•Test 1419
1 Gene
Dentatorubral-Pallidoluysian Atrophy (DRPLA) via the ATN1 CAG Repeat Expansion
Repeat-Primed PCR & Fragment Length
1 - 2 weeks (6 - 10 days STAT)•Test 5999
1 Gene
Hypertrophic Cardiomyopathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 1313
68 Genes
Comprehensive Vitreoretinopathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7941
21 Genes
Cornelia de Lange Syndrome and Related Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10399
42 Genes
TNXB-Related Disorders via the TNXB Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7533
1 Gene
Inherited Bone Marrow Failure Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7359
196 Genes
Klippel-Feil Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12621
6 Genes
Leukodystrophy and Leukoencephalopathy, Adult Onset Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12623
45 Genes
Glaucoma Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10335
24 Genes
Cerebral Small Vessel Disease Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12637
10 Genes
Familial Hemiplegic Migraine Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10161
8 Genes
Top 99 Genetic Causes of Developmental Delay Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12675
99 Genes
Disorders of Copper Metabolism Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12673
6 Genes
Lipodystrophy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12603
29 Genes
Treacher Collins Syndrome/Mandibulofacial Dysostosis/Miller Syndrome/Acrofacial Dysostosis, Nagar Type Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10235
7 Genes
Wilms Tumor Panel
NGS with CNV (PGselect platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10447
29 Genes
TNXB-Related Disorders via the TNXB Gene, Exons 32-44
Sanger Sequencing
3 - 4 weeks (12 - 20 days STAT)•Test 6088
1 Gene
Non-Immune Hydrops Fetalis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12661
149 Genes
Adams-Oliver Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13027
8 Genes
Organic Aciduria Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10391
41 Genes
Comprehensive Neuropathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10427
145 Genes
Septo-optic Dysplasia Spectrum Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (6 - 12 days STAT)•Test 10211
8 Genes
Anterior Segment Dysgenesis Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12003
278 Genes
Amyotrophic Lateral Sclerosis (ALS)/Motor Neuron Disease via the SOD1 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8949
1 Gene
Hereditary Hemolytic Anemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12041
34 Genes
Inherited Platelet Function Disorder Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10371
26 Genes
Familial Hemophagocytic Lymphohistiocytosis-Type 3 (FHL3) via the UNC13D Inversion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 2050
1 Gene
Polydactyly and Syndactyly Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13099
230 Genes
Alnylam Act® hATTR Amyloidosis Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 15139
1 Gene
Nonsyndromic Congenital Heart Disease Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13097
44 Genes
Mitochondrial Disorders Panel (Nuclear Genes Only)
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5077
253 Genes
Lysosomal Storage Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13065
146 Genes
Spinocerebellar Ataxia Type 2 via the ATXN2 CAG Repeat Expansion
Repeat-Primed PCR & Fragment Length
1 - 2 weeks (6 - 10 days STAT)•Test 12976
1 Gene
Marfan Syndrome and Related Aortopathies Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10363
40 Genes
Long QT Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10325
19 Genes
PGmax™ - Comprehensive Inherited Kidney Diseases Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 13990
330 Genes
Noonan Spectrum Disorders/RASopathies Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10327
23 Genes
Cholestasis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10319
70 Genes
Hereditary Cystic Kidney Diseases Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10619
48 Genes
Congenital Anomalies of the Gastrointestinal Tract Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13377
180 Genes
VACTERL Association and Related Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13041
84 Genes
Congenital Diaphragmatic Hernia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13359
65 Genes
PGmax™ - Neonatal Crisis Panel
NGS with CNV (Exome or Genome Platform)
7 - 16 days•Test 7383
Strabismus Syndrome or Congenital Fibrosis of Extraocular Muscles (Ocular Motility Disorder) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 2685
14 Genes
CADASIL1 via the NOTCH3 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 11525
1 Gene
Diamond-Blackfan Anemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3015
23 Genes
Familial Chylomicronemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13025
7 Genes
GNAS-Related Disorders via the GNAS Gene
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 15163
1 Gene
Comprehensive Monogenic Obesity Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 15185
52 Genes
Machado-Joseph Disease (MJD)/Spinocerebellar Ataxia Type 3 (SCA3) via the ATXN3 CAG Repeat Expansion
Repeat-Primed PCR & Fragment Length
1 - 2 weeks (6 - 10 days STAT)•Test 13213
1 Gene
Congenital Diarrhea and Enteropathies Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12647
157 Genes
PGmax™ - Inborn Errors of Immunity/Primary Immunodeficiency (PID) Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 13999
640 Genes
PGmax™ - Primary Immunodeficiency and Malignancy Predisposition Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 19998
712 Genes
PGmax™ - Comprehensive Movement Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 16004
938 Genes
Episodic Ataxia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13383
36 Genes
Oculopharyngeal Muscular Dystrophy via the PABPN1 (GCN) Repeat Expansion
Expansion Assay
1 - 2 weeks (6 - 10 days STAT)•Test 6058
1 Gene
Severe Congenital Neutropenia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10257
42 Genes
Spinocerebellar Ataxia Type 17 via the TBP CAG/CAA Repeat Expansion
Repeat-Primed PCR & Fragment Length
1 - 2 weeks (6 - 10 days STAT)•Test 6059
1 Gene
C9orf72 Gene Hexanucleotide Repeat Expansion
Repeat-Primed PCR & Fragment Length
1 - 2 weeks (6 - 10 days STAT)•Test 151
1 Gene
Female Infertility Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4513
105 Genes
Lynch Syndrome/Constitutional Mismatch Repair Deficiency Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5463
5 Genes
Spinal Muscular Atrophy (SMA) via MLPA of SMN1 and SMN2
Multiplex Ligation-Dependent Probe Amplification Assay
2 - 3 weeks (6 - 11 days STAT)•Test 6064
2 Genes
X-linked Spinal and Bulbar Muscular Atrophy (Kennedy Disease) via the AR Gene CAG Repeat Expansion
Repeat-Primed PCR & Fragment Length
1 - 2 weeks (6 - 10 days STAT)•Test 7501
1 Gene
Autoimmune Lymphoproliferative Syndrome/ALPS Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4921
16 Genes
Hereditary Breast, Ovarian, Pancreatic, and Prostate Cancer Syndrome BRCA1/2 Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5451
2 Genes
Crigler-Najjar Syndrome and Gilbert Syndrome via the UGT1A1 Gene
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7851
1 Gene
Hereditary Breast and Gynecological Cancer Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5453
19 Genes
Premature Ovarian Failure (POF) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5285
21 Genes
Combined Pituitary Hormone Deficiency (CPHD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5287
9 Genes
Hypogonadotropic Hypogonadism/Kallmann Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5243
38 Genes
Alpha Thalassemia Panel
Sanger Sequencing and MLPA
3 - 4 weeks (12 - 19 days STAT)•Test 6090
2 Genes
Alpha Thalassemia Deletion/Duplication and Constant Spring Panel
Multiplex Ligation-Dependent Probe Amplification Assay
2 - 3 weeks (6 - 11 days STAT)•Test 6070
2 Genes
Hereditary Hemochromatosis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10243
7 Genes
Schwannomatosis Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10107
3 Genes
Catecholaminergic Polymorphic Ventricular Tachycardia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10249
11 Genes
Porphyria Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10255
8 Genes
Kallmann Syndrome (KS) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10279
10 Genes
Periodic Fever Syndromes Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10315
13 Genes
Craniofacial Malformations Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10343
19 Genes
Currarino Syndrome via the MNX1 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9829
1 Gene
Neurofibromatosis Type 1 (NF1) and Legius Syndrome Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10099
2 Genes
Infantile Myofibromatosis Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10091
2 Genes
Hereditary Multiple Osteochondromas and Related Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10085
6 Genes
Ellis-van Creveld Syndrome (EVC) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10079
2 Genes
CADASIL and CARASIL Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10073
2 Genes
Lymphedema Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10303
14 Genes
3-Methylcrotonyl-CoA Carboxylase Deficiency Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (6 - 12 days STAT)•Test 10069
2 Genes
Alzheimer's Disease, Familial, Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3409
3 Genes
Bardet-Biedl Syndrome (BBS) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (6 - 12 days STAT)•Test 10349
27 Genes
Metabolic Myopathies, Rhabdomyolysis and Exercise Intolerance Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10049
158 Genes
PGmax™ - Comprehensive Congenital Heart Disease Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 13008
509 Genes
Comprehensive Pediatric Solid Tumor Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7973
137 Genes
Rubinstein-Taybi Syndrome and Floating-Harbor Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10141
3 Genes
Neurohypophyseal Diabetes Insipidus and Nephrogenic Diabetes Insipidus Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10137
3 Genes
Alport Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10147
4 Genes
Xeroderma Pigmentosum (XP) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10259
9 Genes
von Willebrand Disease Types 1, 2, and 3 via the VWF Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 11801
1 Gene
Congenital Stationary Night Blindness Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4319
17 Genes
Corneal Dystrophies Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3029
27 Genes
Multiple Endocrine Neoplasia Type 2A (MEN2A), Type 2B (MEN2B), and Familial Medullary Thyroid Carcinoma (FMTC) via the RET Gene
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4673
1 Gene
Chronic Progressive External Ophthalmoplegia (CPEO/PEO) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10507
13 Genes
Inherited Retinal Dystrophies Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4379
363 Genes
IRF6-Related Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12081
2 Genes
Autosomal Dominant Polycystic Kidney Disease via the PKD1 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10453
1 Gene
Hypermethioninemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10133
4 Genes
Hereditary Myelodysplastic Syndrome (MDS) / Acute Myeloid Leukemia (AML) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10293
12 Genes
Multiple Epiphyseal Dysplasia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10247
10 Genes
Neurodegeneration with Brain Iron Accumulation Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 2695
16 Genes
Comprehensive Neuromuscular Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10433
266 Genes
Leukodystrophy and Leukoencephalopathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5495
212 Genes
Stargardt Disease (STGD) and Macular Dystrophies Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4315
28 Genes
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)/Dysplasia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (6 - 12 days STAT)•Test 10261
18 Genes
Kabuki Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10173
9 Genes
Peroxisomal Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10369
27 Genes
Congenital Adrenal Hyperplasia (CAH) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12053
7 Genes
Gaucher Disease via the GBA1/GBA Gene
Sanger Sequencing
3 - 4 weeks (12 - 20 days STAT)•Test 479
1 Gene
Iron-Refractory Iron Deficiency Anemia (IRIDA) via the TMPRSS6 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8027
1 Gene
Congenital Methemoglobinemia via the CYB5R3 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9947
1 Gene
Cystinosis via the CTNS Gene, 57-kb Deletion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 1636
1 Gene
Protein S Deficiency via the PROS1 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9901
1 Gene
Beta-Thalassemia and Hemoglobinopathy via the HBB Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7693
1 Gene
Blepharophimosis-Ptosis-Epicanthus Inversus syndrome (BPES) via the FOXL2 Gene
Sanger Sequencing
3 - 4 weeks (12 - 20 days STAT)•Test 1673
1 Gene
Protein C Deficiency via the PROC Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8493
1 Gene
Congenital Central Hypoventilation Syndrome (CCHS) via the PHOX2B Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8967
Glucose-6-Phosphate Dehydrogenase Deficiency via the G6PD Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7657
1 Gene
Hemophilia B via the F9 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7641
1 Gene
Ornithine Transcarbamylase Deficiency via the OTC Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9723
1 Gene
Short Chain Acyl-CoA Dehydrogenase Deficiency via the ACADS Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8461
1 Gene
Birt-Hogg-Dube Syndrome via the FLCN Gene
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8409
1 Gene
Retinoblastoma via the RB1 Gene
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4501
1 Gene
Holt-Oram Syndrome (HOS) via the TBX5 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8475
1 Gene
Nemaline Myopathy via the NEB Exon 55 Deletion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 356
1 Gene
SHOX-Related Disorders via the SHOX Gene
Sanger Sequencing
3 - 4 weeks (12 - 20 days STAT)•Test 626
1 Gene
Glycogen Storage Disease Type Ia via the G6PC1/G6PC Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9601
1 Gene
Cerebral Cavernous Malformations via the CCM2 Gene, Exons 2-10 Deletion
Targeted PCR
3 weeks (STAT 2 weeks)•Test 124
1 Gene
Von Hippel-Lindau Disease via VHL Gene
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7523
1 Gene
Beckwith-Wiedemann Syndrome via the CDKN1C Gene
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10005
1 Gene
Maple Syrup Urine Disease Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3281
3 Genes
Multiple Endocrine Neoplasia Type 1 via the MEN1 Gene
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7503
1 Gene
PTEN Hamartoma Tumor Syndrome via the PTEN Gene
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7513
1 Gene
Trimethylaminuria via the FMO3 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8503
1 Gene
Krabbe Disease via the GALC Exons 11-17 (502T/Del)
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 632
1 Gene
Interstitial Lung Disease Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5211
24 Genes
Comprehensive Arrhythmia and Cardiomyopathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 2663
169 Genes
Thrombocytopenia Absent Radius (TAR) Syndrome via the RBM8A 1q21.1 Deletion
CMA
3 - 5 weeks (6 - 10 days STAT)•Test 1718
1 Gene
Nemaline Myopathy via the NEB Gene, Exons 82-105 (Triplicate Repeat Region)
Sanger Sequencing
3 - 4 weeks (12 - 19 days STAT)•Test 2079
1 Gene
Inherited Ichthyoses and Related Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4929
68 Genes
Thrombocytopenia Absent Radius (TAR) Syndrome via the RBM8A Gene
Sanger Sequencing
3 - 4 weeks (12 - 20 days STAT)•Test 1721
1 Gene
Congenital Hypothyroidism and Thyroid Hormone Resistance Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 1989
26 Genes
Tay-Sachs Disease via the French Canadian Deletion in the HEXA Gene
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 1450
1 Gene
Hypomagnesemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3025
16 Genes
Glycogen Storage Disease Type II (Pompe Disease) via the GAA Gene, Exon 18 Deletion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 234
1 Gene
PMP22-Related Neuropathies via the PMP22 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9033
1 Gene
Y Chromosome Deletion Analysis
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 3740
1 Gene
Niemann-Pick Disease Type C Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3425
2 Genes
Hypoparathyroidism Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 2653
28 Genes
Retinitis Pigmentosa Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 2699
82 Genes
Neuronal Ceroid Lipofuscinosis 3 (Batten Disease) via the CLN3 c.461-280_677+382 Deletion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 3739
1 Gene
Leber Congenital Amaurosis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4313
28 Genes
Propionic Acidemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3291
2 Genes
Cystic Fibrosis and CF-Related Disorders via the CFTR Gene
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3035
1 Gene
Cerebral Cavernous Malformations Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (6 - 12 days STAT)•Test 1943
3 Genes
Hemophilia A via the F8 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3077
1 Gene
Factor VII Deficiency via the F7 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4149
1 Gene
Fragile X Syndrome via FMR1 CGG Repeat Expansion
Repeat-Primed PCR & MS-PCR
1 - 2 weeks (6 - 10 days STAT)•Test 558
1 Gene
Huntington Disease via the HTT CAG Repeat Expansion
Repeat-Primed PCR & Fragment Length
1 - 2 weeks (6 - 10 days STAT)•Test 2299
1 Gene
Primary Hyperoxaluria Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4531
3 Genes
Nemaline Myopathy (NEM2) via the Nebulin (NEB) Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 1772
1 Gene
Severe MTHFR Deficiency via the MTHFR Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7291
1 Gene
Mitochondrial Trifunctional Protein Deficiency and Long-Chain 3-Hydroxyacyl CoA Dehydrogenase Deficiency Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10635
2 Genes
Tuberous Sclerosis Complex (TSC) Deletion/Duplication Testing via MLPA
Multiplex Ligation-Dependent Probe Amplification Assay
2 - 3 weeks (6 - 11 days STAT)•Test 2055
2 Genes
Tuberous Sclerosis Complex (TSC) Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10661
2 Genes
Generalized Arterial Calcification of Infancy (GACI) and Pseudoxanthoma Elasticum (PXE) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7545
2 Genes
Marfan Syndrome via the FBN1 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3057
1 Gene
Glycogen Storage Disease Type IV via the GBE1 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5413
1 Gene
Dystrophinopathy via the DMD Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 1773
Hereditary Colorectal Cancer and Polyposis Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5467
25 Genes
Prostate Cancer Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5459
16 Genes
Fanconi Anemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10361
22 Genes
Renal Cancer Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (6 - 12 days STAT)•Test 1331
25 Genes
Melanoma Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5473
10 Genes
Biotinidase Deficiency via the BTD Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9551
1 Gene
Loeys-Dietz Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 15737
6 Genes
Charcot-Marie-Tooth (CMT) - Comprehensive Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10419
83 Genes
Distal Arthrogryposis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10289
12 Genes
Hemophilia C via the F11 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7079
1 Gene
Hypospadias Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 6905
73 Genes
Ambiguous Genitalia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 6903
85 Genes
DICER1 Syndrome via the DICER1 Gene
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3041
1 Gene
Hyperphenylalaninemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3403
6 Genes
Shwachman-Diamond Syndrome via the SBDS Gene
Sanger Sequencing
3 - 4 weeks (12 - 19 days STAT)•Test 1289
1 Gene
Fabry Disease via the GLA Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7681
1 Gene
Congenital Disorders of Glycosylation (CDG) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10625
54 Genes
Butyrylcholinesterase Deficiency via the BCHE Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7873
1 Gene
Wilson Disease / Hepatolenticular Degeneration via the ATP7B Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7871
1 Gene
Canavan Disease (Aspartoacylase Deficiency) via the ASPA Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9533
1 Gene
Hypophosphatasia via the ALPL Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7573
1 Gene
X-Linked Adrenoleukodystrophy via the ABCD1 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7557
1 Gene
Carnitine Palmitoyltransferase II Deficiency via the CPT2 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9563
1 Gene
Cardiac Arrhythmia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10423
68 Genes
Urea Cycle Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10273
9 Genes
Chronic Pancreatitis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10191
7 Genes
Wolfram Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10057
2 Genes
Primary Ciliary Dyskinesia (PCD)/Immotile Cilia Syndrome and Cystic Fibrosis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10415
51 Genes
Short Rib Skeletal Dysplasia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10347
19 Genes
Optic Atrophy and Neuropathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10331
70 Genes
Brugada Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10329
17 Genes
Congenital Central Hypoventilation Syndrome (CCHS) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10239
7 Genes
Primary Periodic Paralysis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10139
3 Genes
Waardenburg Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10055
8 Genes
Ectodermal Dysplasia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10223
6 Genes
Pendred Syndrome and Nonsyndromic Hearing Loss Associated with Enlarged Vestibular Aqueduct Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10051
3 Genes
Craniosynostosis and Related Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10197
5 Genes
Idiopathic Basal Ganglia Calcification Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10171
4 Genes
Nephrolithiasis and Nephrocalcinosis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10395
30 Genes
Primary Ciliary Dyskinesia (PCD)/Immotile Cilia Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10411
50 Genes
Episodic Pain Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10123
4 Genes
Hirschsprung Disease (Non-syndromic) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10225
6 Genes
Pulmonary Fibrosis and Surfactant Dysfunction Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10287
10 Genes
Familial Hemophagocytic Lymphohistiocytosis (FHL) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10377
29 Genes
Bleeding Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10425
85 Genes
Congenital Hyperinsulinism Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10265
9 Genes
Familial Hypercholesterolemia (FH) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10163
8 Genes
Congenital Fibrinogen Deficiency Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10119
3 Genes
Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10229
6 Genes
Pseudohypoaldosteronism Type I Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10179
4 Genes
Pediatric Cataracts Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10413
41 Genes
Familial Hypocalciuric Hypercalcemia (FHH) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10125
3 Genes
Branchiootorenal Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10115
3 Genes
Alagille Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10071
2 Genes
Cystinuria Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10075
2 Genes
Autosomal Recessive Polycystic Kidney Disease (ARPKD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10463
3 Genes
Ciliopathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10431
133 Genes
Autosomal Dominant Polycystic Kidney Disease via MLPA of PKD1
Multiplex Ligation-Dependent Probe Amplification Assay
2 - 3 weeks (6 - 11 days STAT)•Test 2058
1 Gene
Malignant Hyperthermia Susceptibility Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10059
3 Genes
Distal Renal Tubular Acidosis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10159
4 Genes
Hermansky-Pudlak Syndrome (HPS) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10269
11 Genes
Dementia, Plus APOE Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 15779
19 Genes
Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10359
38 Genes
Epidermolysis Bullosa and Related Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3003
18 Genes
Stickler Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10271
12 Genes
Sterol Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13319
12 Genes
PGmax™ - Skeletal Disorders and Joint Problems Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 10631
694 Genes
Hereditary Spastic Paraplegia Comprehensive Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 2673
106 Genes
Autism Spectrum Disorders (ASD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5061
170 Genes
Deafness, Autosomal Recessive 16 (DFNB16) via MLPA of STRC
Multiplex Ligation-Dependent Probe Amplification Assay
2 - 3 weeks (6 - 11 days STAT)•Test 12548
1 Gene
GJB2 Regulatory Element Deletion Testing (GJB6-D13S1830 and GJB6-D13S1854)
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 2997
1 Gene
Dystonia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3017
17 Genes
Congenital Myasthenic Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10321
32 Genes
Hyperammonemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10407
63 Genes
Neonatal Respiratory Distress Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13349
5 Genes
Bone Fragility and Fracture Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12679
72 Genes
Glycine Encephalopathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10129
11 Genes
Microphthalmia/Anophthalmia/Coloboma Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10333
55 Genes
Hydrocephalus Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7939
38 Genes
Disorders of Fatty Acid Oxidation (FAOD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10381
33 Genes
Pan Cardiomyopathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5263
117 Genes
Male Infertility Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4511
137 Genes
Hereditary Paraganglioma and Pheochromocytoma Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 1329
12 Genes
Hereditary Ovarian Cancer Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5469
30 Genes
Breast Cancer - High Risk Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5431
7 Genes
Pancreatic Cancer Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5461
18 Genes
Comprehensive Hereditary Cancer Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5471
117 Genes
Gastric Cancer Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10449
19 Genes
Early-Onset High Myopia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 15487
137 Genes
Leber Hereditary Optic Neuropathy (LHON) - Targeted Testing for 3 Common Pathogenic Variants
Sanger Sequencing
3 - 4 weeks (12 - 20 days STAT)•Test 15667
3 Genes
Hereditary Hearing Loss and Deafness Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5063
234 Genes
Usher Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10053
12 Genes
Common Hereditary Cancer Screening Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 15723
55 Genes
PGmax™ - Comprehensive Ocular Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 12005
644 Genes
Coffin-Siris Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10221
12 Genes
PGmax™ - Comprehensive Inherited Metabolic Disorders and Mitochondrial Disorders (Nuclear Genes only) Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 16006
1317 Genes
Tooth Agenesis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3021
9 Genes
PGmax™ - Intellectual Disability, Epilepsy, and Autism (IDEA) Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 5045
2527 Genes
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 15423
160 Genes
Elevated Levels of C5-hydroxyacylcarnitine (C5-OH) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4999
7 Genes
Lynch Syndrome via MLPA of PMS2
Multiplex Ligation-Dependent Probe Amplification Assay
2 - 3 weeks (6 - 11 days STAT)•Test 6062
1 Gene
Angelman/Prader Willi Syndrome by MS-MLPA
Methylation-Specific Multiplex Ligation-Dependent Probe Amplification
2 - 3 weeks (6 - 11 days STAT)•Test 2056
2 Genes
Gitelman Syndrome via the SLC12A3 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4503
1 Gene
Maturity Onset Diabetes of the Young (MODY) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10305
18 Genes
Glycogen Storage Disease Type II (Pompe Disease) via the GAA Gene
Sequencing with CNV PGxome
N/A•Test 9605
1 Gene
Rapid Whole Genome Chromosomal Microarray (CMA-ISCA) Test
CMA
6 - 10 days•Test 12684
Holoprosencephaly, Autosomal Dominant, Nonsyndromic, Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10317
14 Genes
Hermansky-Pudlak Syndrome via the HPS3 Gene, Exon 1 Deletion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 759
1 Gene
Parkinson Disease and Parkinsonism Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10623
70 Genes
LHCGR-related Disorders via the LHCGR Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7729
1 Gene
Amyotrophic Lateral Sclerosis (ALS) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10155
29 Genes
Heterotaxy, Situs Inversus and Kartagener's Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10405
48 Genes
Elevated C5-DC Acylcarnitine via the GCDH Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16037
1 Gene
Movement Disorder Genetic Test Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 16004
938 Genes
Monogenic Diabetes Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4303
54 Genes
Cholestasis Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 16229
143 Genes
X-Linked Adrenoleukodystrophy (X-ALD) Newborn Screening Reflex Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 12671
26 Genes